Materials and Methods for Treatment of Hemoglobinopathies
Copyright © Targeted News Service 2024
2024-11-05
ALEXANDRIA, Virginia, Nov. 5 -- VERTEX PHARMACEUTICALS INC., Boston, Massachusetts has been assigned a patent (No. US 12134767 B2, initially filed June 23, 2020) developed by Matthew Hebden Porteus, Stanford, California, for "Materials and methods for treatment of hemoglobinopathies." . . .